William Blair downgraded GoHealth (GOCO) to Market Perform from Outperform. Q3 revenue and Medicare submissions were below the firm’s expectations as the company pulled back on new enrollment growth, aligning with insurer actions to prioritize profitability and member retention over board member expansion, the analyst tells investors in a research note. The firm added that it believes the decision to limit cash burn is prudent given he challenging market dynamic, though it downgrades the shares given market headwinds that will likely persist through 2026,unccertatinty on GoHealth’s ability to generate sustainable positive cash flow, and limited progress in diversifying its business model.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOCO:
- GoHealth downgraded to Market Perform from Outperform at William Blair
- GoHealth files to sell 4.77M shares of Class A common stock for holders
- GoHealth price target lowered to $10 from $20 at Noble Capital
- GoHealth, Inc. Reports Strategic Shift Amid Market Changes
- GoHealth’s Strategic Shift: Earnings Call Insights
